Phospho-ATF1 (Ser63) Antibody

What is ATF1 and what cellular processes does it regulate?

ATF1 (Activating Transcription Factor 1) is a stimulus-induced transcription factor belonging to the ATF subfamily and bZIP (basic-region leucine zipper) family. It binds to the cAMP response element (CRE) with consensus sequence 5'-GTGACGT[AC][AG]-3', which is present in many viral and cellular promoters . ATF1 plays critical roles in:

• Cellular survival and proliferation

• Transcriptional regulation of downstream target genes related to growth and survival

• Repression of ferritin H and other antioxidant detoxification genes

• Cell transformation processes

ATF1 is located primarily in the nucleus and mediates PKA-induced stimulation of CRE-reporter genes .

Why is phosphorylation of ATF1 at Ser63 functionally significant?

Phosphorylation at Ser63 is a critical post-translational modification that enhances ATF1's transcriptional activity. This phosphorylation:

• Occurs in the kinase-inducible (KID) domain

• Significantly enhances ATF1's transactivation and transcriptional activities

• Increases cell transformation potential

• Alters protein-protein interactions with transcriptional co-activators

• Enables ATF1 to respond to various extracellular signals including stress and growth factors

Prior to the discovery of phosphorylation at other sites like Ser198, phosphorylation at Ser63 was the only known post-translational regulatory mechanism of ATF1 .

Which kinases phosphorylate ATF1 at Ser63?

Several serine-threonine kinases can phosphorylate ATF1 at Ser63:

Interestingly, HIPK2 (homeodomain-interacting protein kinase 2), a DNA-damage-responsive nuclear kinase, phosphorylates ATF1 at Ser198 but not at Ser63 .

What are the validated applications for Phospho-ATF1 (Ser63) antibodies?

Phospho-ATF1 (Ser63) antibodies have been validated for multiple research applications:

Most commercial antibodies show reactivity to human and mouse ATF1, with predicted reactivity in other species like pig, zebrafish, and bovine based on sequence homology .

How should I optimize Western blot conditions for detecting phosphorylated ATF1?

Optimal detection of phosphorylated ATF1 requires careful attention to sample preparation and experimental conditions:

• Sample preparation:

  • Lyse cells directly in hot SDS-PAGE sample buffer to preserve phosphorylation

  • Include phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate) in all buffers

  • Process samples quickly and keep them cold

  • Consider using phosphatase treatment as a negative control

• Blocking and antibody incubation:

  • Use 5% BSA in TBST (not milk) for blocking to avoid phosphatases in milk

  • Incubate primary antibody at 4°C overnight at recommended dilutions (typically 1:500-1:1000)

  • Use gentle washing to preserve phospho-epitopes

• Controls:

  • Include positive controls such as lysates from cells treated with PKA activators or insulin

  • Run a phosphatase-treated sample as a negative control to confirm specificity

  • Consider using ATF1 Ser63Ala mutant samples if available

Researchers have successfully detected p-ATF1-Ser63 in insulin-treated HT29 cell lysates showing a clear band at 29kDa .

How can I validate the specificity of a Phospho-ATF1 (Ser63) antibody?

Validating phospho-specific antibodies is critical for reliable research outcomes:

• Competing peptide assays:

  • Use phosphorylated and non-phosphorylated peptides in parallel ELISA assays

  • A specific antibody should show strong binding to phospho-peptide but minimal binding to non-phospho-peptide

• Phosphatase treatment:

  • Treat duplicate samples with lambda phosphatase before Western blotting

  • The phospho-specific band should disappear after phosphatase treatment

• Mutant protein expression:

  • Express wild-type ATF1 and Ser63Ala-mutant ATF1 in cells

  • A specific antibody should detect wild-type but not the Ser63Ala mutant after stimulation

• Stimulation experiments:

  • Compare unstimulated cells with cells treated with PKA activators or other stimuli known to induce Ser63 phosphorylation

  • Observe increased signal intensity after stimulation

• Cross-reactivity assessment:

  • Test for cross-reactivity with phosphorylated CREB (at Ser133) due to sequence homology

  • Use recombinant proteins or cells expressing only ATF1 or CREB to confirm specificity

How does ATF1 phosphorylation at different sites affect its function?

ATF1 function is regulated by phosphorylation at multiple sites, with distinct functional outcomes:

Research by Huang et al. demonstrated that HIPK2 phosphorylates ATF1 at Ser198 but not Ser63, and both phosphorylation events activate ATF1 independently, suggesting parallel regulatory mechanisms . The functional differences include:

• Ser63 phosphorylation is primarily responsive to cAMP and stress signals

• Ser198 phosphorylation responds to DNA damage through HIPK2

• Thr184 phosphorylation appears linked to metastatic processes

Interestingly, when ATF1-GAL4 fusion proteins were tested in luciferase reporter assays, both PKA (which phosphorylates Ser63) and HIPK2 (which phosphorylates Ser198) enhanced ATF1-dependent transcription to similar degrees, suggesting functional convergence despite different phosphorylation sites .

What is the relationship between ATF1 (Ser63) and CREB (Ser133) phosphorylation?

ATF1 and CREB are closely related transcription factors with significant sequence homology, particularly in their phosphorylation domains:

• Structural similarity:

  • ATF1 Ser63 and CREB Ser133 are located in homologous kinase-inducible domains

  • Both sites are flanked by similar amino acid sequences, explaining why some antibodies detect both phospho-proteins

• Shared kinases:

  • PKA, MSK1, and other kinases can phosphorylate both ATF1 at Ser63 and CREB at Ser133

  • Similar stimuli often lead to concurrent phosphorylation of both proteins

• Functional overlap:

  • Both phosphorylated forms interact with the transcriptional co-activator CBP/p300

  • Both regulate overlapping sets of CRE-containing genes

  • Functional redundancy exists in some contexts, requiring careful interpretation of results

• Experimental considerations:

  • Use monoclonal antibody 10E9 to detect both phosphorylated forms simultaneously

  • For specific detection, use antibodies validated to distinguish between p-ATF1 (Ser63) and p-CREB (Ser133)

  • Consider protein size differences (CREB: ~43kDa; ATF1: ~29kDa) when interpreting Western blots

How does ATF1 phosphorylation regulate gene expression in stress responses?

ATF1 phosphorylation plays a crucial role in regulating gene expression during cellular stress:

• Antioxidant gene regulation:

  • Unphosphorylated ATF1 binds to the antioxidant response element (ARE) of ferritin H and represses its expression

  • When phosphorylated, ATF1 releases from the ARE, allowing increased expression of ferritin H and other antioxidant genes

  • This mechanism helps cells respond to oxidative and chemical stress

• Stress-responsive phosphorylation pathway:

  • Cellular stress activates p38 MAPK and other stress-responsive kinases

  • These kinases phosphorylate MSK1, which in turn phosphorylates ATF1 at Ser63

  • Phosphorylated ATF1 alters its binding to CRE elements in stress-responsive genes

• Dual regulation by different phosphorylation sites:

  • DNA damage activates HIPK2, which phosphorylates ATF1 at Ser198

  • This provides a different stress-responsive pathway distinct from the PKA/MSK1-mediated Ser63 phosphorylation

  • The combination of phosphorylation events allows integration of multiple stress signals

In experiments with HepG2 cells, ATF1 repressed ferritin H ARE-dependent transcription, but this repression was relieved when ATF1 was phosphorylated, demonstrating a direct link between ATF1 phosphorylation status and stress-responsive gene expression .

Why might I observe cross-reactivity with CREB when using Phospho-ATF1 (Ser63) antibodies?

Cross-reactivity between phospho-ATF1 and phospho-CREB antibodies is a common challenge:

• Sequence homology:

  • The regions surrounding ATF1 Ser63 and CREB Ser133 share significant sequence similarity

  • The phospho-epitope recognized by many antibodies includes several amino acids before and after the phosphorylated residue

• Antibody generation methods:

  • Many phospho-ATF1 (Ser63) antibodies are generated using synthetic phospho-peptides that may share homology with CREB

  • Polyclonal antibodies contain multiple antibody clones recognizing different epitope regions, increasing cross-reactivity risk

• Verification methods:

  • Examine antibody documentation for cross-reactivity testing data

  • Look for specific notes about CREB cross-reactivity in product data sheets

  • Confirm using recombinant proteins or knockout cells lacking either ATF1 or CREB

• Distinguishing strategies:

  • Use molecular weight differences (ATF1: ~29kDa; CREB: ~43kDa) in Western blots

  • Perform immunodepletion with one protein to confirm identity of the other

  • Consider using more specific monoclonal antibodies when critical

Some antibodies like the 10E9 clone are deliberately designed to detect both phosphorylated proteins for studying their combined activity .

How can I preserve phosphorylation status during sample preparation?

Maintaining phosphorylation status is critical for accurate analysis:

• Immediate sample processing:

  • Process samples as quickly as possible after collection

  • For cultured cells, remove media and immediately add lysis buffer

  • For tissues, flash-freeze in liquid nitrogen immediately after collection

• Phosphatase inhibitors:

  • Include multiple phosphatase inhibitors in all buffers:

    • Sodium fluoride (50mM) for serine/threonine phosphatases

    • Sodium orthovanadate (1mM) for tyrosine phosphatases

    • β-glycerophosphate (10mM) for serine/threonine phosphatases

    • Phosphatase inhibitor cocktails containing multiple inhibitors

• Lysis conditions:

  • Use denaturing lysis conditions when possible (direct lysis in hot SDS sample buffer)

  • If non-denaturing lysis is required, keep samples cold (4°C) throughout processing

  • Avoid multiple freeze-thaw cycles of protein lysates

• Positive controls:

  • Include samples from cells treated with phosphatase inhibitors like okadaic acid

  • Use stimulated samples (e.g., insulin-treated cells) as positive controls

  • Consider synthetic phosphopeptides as standards in quantitative assays

For experiments examining ATF1 phosphorylation kinetics, rapid preservation of phosphorylation status is particularly critical, as demonstrated in studies examining the time course of ATF1 phosphorylation after stimulation .

What factors might affect the phosphorylation status of ATF1 in experimental systems?

Multiple factors can influence ATF1 phosphorylation status, which must be controlled in experimental designs:

• Cell culture conditions:

  • Serum components contain growth factors that may induce basal phosphorylation

  • Cell density affects stress levels and signaling pathways

  • Time since last media change affects nutrient availability and stress

• Stress conditions:

  • Mechanical stress during handling can activate stress kinases

  • Temperature changes (even brief exposures to room temperature)

  • Hypoxia during long procedures before lysis

• Pharmacological considerations:

  • PKA activators (e.g., forskolin, dibutyryl-cAMP) strongly induce Ser63 phosphorylation

  • MAPK pathway inhibitors (e.g., U0126, SB203580) reduce stress-induced phosphorylation

  • Phosphodiesterase inhibitors (e.g., IBMX) prolong cAMP signaling, enhancing phosphorylation

• Experimental timing:

  • ATF1 phosphorylation follows stimulus-specific kinetics

  • Insulin treatment shows rapid phosphorylation (within 15 minutes)

  • Consider time-course experiments to capture peak phosphorylation

• Cross-pathway interactions:

  • Activation of one signaling pathway may influence others through crosstalk

  • Combined stressors may have synergistic or antagonistic effects on phosphorylation

When designing experiments to study ATF1 phosphorylation, carefully standardize these variables and include appropriate controls for each condition.

What is the role of Phospho-ATF1 in cancer biology?

Recent research has revealed significant roles for phosphorylated ATF1 in cancer:

• Novel phosphorylation sites and cancer progression:

  • Phosphorylation at Thr184 has been recently identified as promoting metastasis in gastric cancer

  • This newly discovered phosphorylation site regulates Matrix metallopeptidase 2 (MMP2), facilitating invasion and metastasis

• Fusion proteins in sarcomas:

  • The EWS-ATF1 fusion protein resulting from t(12;22) chromosomal translocation is found in clear cell sarcoma

  • This fusion protein plays a vital role in maintaining viability, tumorigenicity, and metastatic potential

  • Phosphorylation may affect the activity of these fusion proteins

• Transcriptional regulation of cancer-related genes:

  • Phosphorylated ATF1 regulates genes involved in cellular proliferation and survival

  • In some contexts, ATF1 phosphorylation enhances cell transformation

  • The balance between different phosphorylation sites may determine oncogenic potential

• Therapeutic implications:

  • Targeting the kinases that phosphorylate ATF1 may offer therapeutic approaches

  • Monitoring phospho-ATF1 levels could serve as a biomarker for certain cancer types

  • Understanding the interaction between different phosphorylation sites provides new therapeutic opportunities

The discovery that phosphorylation at different sites (Ser63, Ser198, Thr184) affects ATF1 function differently suggests complex regulatory mechanisms that could be exploited for targeted cancer therapies .

What emerging techniques are advancing the study of ATF1 phosphorylation?

Several cutting-edge technologies are enhancing our understanding of ATF1 phosphorylation:

• Cell-based phosphorylation assays:

  • Lysate-free, high-throughput colorimetric cell-based ELISA kits allow detection of phospho-ATF1 directly in fixed cells

  • These methods preserve spatial information and avoid artifacts from cell lysis

• Phospho-specific antibody arrays:

  • Multi-plex phosphorylation detection systems allow simultaneous analysis of ATF1 phosphorylation alongside other signaling proteins

  • These approaches reveal pathway interactions not evident from single-protein studies

• Mass spectrometry approaches:

  • Phosphoproteomics using high-resolution mass spectrometry can identify novel phosphorylation sites

  • Quantitative MS methods can measure stoichiometry of different phosphorylation events

  • This approach led to the discovery of the Thr184 phosphorylation site

• CRISPR-based functional studies:

  • Precise genome editing to create Ser-to-Ala mutations at endogenous loci

  • Development of phosphorylation-specific reporters for live-cell imaging

  • Creation of cellular models with specific kinase knockouts to dissect phosphorylation pathways

• Structural biology advances:

  • Cryo-EM structures of phosphorylated transcription factor complexes

  • Molecular dynamics simulations to understand how phosphorylation alters protein conformation

  • These approaches help explain how different phosphorylation sites distinctly affect protein function

These technological advances are expected to reveal new layers of complexity in ATF1 phosphorylation dynamics and their functional consequences.

How does ATF1 phosphorylation contribute to cellular stress responses and adaptation?

ATF1 phosphorylation plays a central role in coordinating cellular responses to various stressors:

• Oxidative stress regulation:

  • ATF1 represses ferritin H and other antioxidant genes in basal conditions

  • Upon stress-induced phosphorylation, this repression is relieved, allowing antioxidant gene expression

  • This mechanism provides adaptive protection against oxidative damage

• Integration of multiple stress signals:

  • Different stressors activate distinct kinases that phosphorylate ATF1 at different sites:

    • cAMP pathway activates PKA → Ser63 phosphorylation

    • DNA damage activates HIPK2 → Ser198 phosphorylation

    • Other stresses may target additional sites like Thr184

  • This multi-site phosphorylation enables nuanced responses to different stress types

• Temporal coordination of stress responses:

  • Each phosphorylation event follows specific kinetics

  • The combination of different phosphorylation events allows temporal coding of stress responses

  • This enables both immediate and sustained adaptive responses

• Cross-talk with other transcription factors:

  • Phosphorylated ATF1 interacts with various transcriptional partners

  • These interactions create combinatorial regulation of stress-responsive genes

  • The phosphorylation status influences which partners ATF1 can interact with

Research in HepG2 cells demonstrated that ATF1 phosphorylation dynamically regulates ferritin H expression via the ARE, providing a mechanistic link between phosphorylation status and specific stress responses . This exemplifies how post-translational modifications of transcription factors allow cells to fine-tune their adaptive responses to environmental challenges.